The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer

Published:2016-09-30 Issue:11 Volume:16 Page:1109-1118
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Fallahi Poupak,Ferrari Silvia Martina,Baldini Enke,Biricotti Marco,Ulisse Salvatore,Materazzi Gabriele,Miccoli Paolo,Antonelli Alessandro

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/14737140.2016.1238764

Reference82 articles.

1. Medullary thyroid cancer

2. Hirschsprungʼs Disease in a Family with Multiple Endocrine Neoplasia Type 2

3. Multiple Endocrine Neoplasia Type 2a Associated with Cutaneous Lichen Amyloidosis

4. Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy

5. RET TKI: Potential Role in Thyroid Cancers

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 aberrantly elevates mitochondrial bioenergetics to induce robust virus propagation;Signal Transduction and Targeted Therapy;2024-05-11

2. Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents;Cell Communication and Signaling;2024-04-15

3. Targeting phospholipase C using synthetic inhibitors of EGFR signaling for cancer treatment;Phospholipases in Physiology and Pathology;2023

4. Daily Management of Patients on Multikinase Inhibitors’ Treatment;Frontiers in Oncology;2022-07-04

5. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin;Seminars in Cancer Biology;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3